These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 9394809)

  • 1. Influence of complement on the allospecific antibody response to a primary vascularized organ graft.
    Pratt JR; Harmer AW; Levin J; Sacks SH
    Eur J Immunol; 1997 Nov; 27(11):2848-53. PubMed ID: 9394809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of complement inhibition with soluble complement receptor-1 on vascular injury and inflammation during renal allograft rejection in the rat.
    Pratt JR; Hibbs MJ; Laver AJ; Smith RA; Sacks SH
    Am J Pathol; 1996 Dec; 149(6):2055-66. PubMed ID: 8952538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model.
    Koch M; Broecker V; Heratizadeh A; Doege C; Strehlau J; Mengel M; Nashan B
    Transpl Immunol; 2008 Jul; 19(3-4):187-91. PubMed ID: 18595711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
    Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Permanent acceptance of liver allografts by intraportal injection of donor spleen cells in rats.
    Nakano Y; Monden M; Valdivia LA; Gotoh M; Tono T; Mori T
    Surgery; 1992 Jun; 111(6):668-76. PubMed ID: 1595063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
    Siemionow MZ; Izycki DM; Zielinski M
    Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The indirect pathway of allorecognition. The occurrence of self-restricted T cell recognition of allo-MHC peptides early in acute renal allograft rejection and its inhibition by conventional immunosuppression.
    Gallon L; Watschinger B; Murphy B; Akalin E; Sayegh MH; Carpenter CB
    Transplantation; 1995 Feb; 59(4):612-6. PubMed ID: 7878766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of acquired thymic unresponsiveness to renal allografts. Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy.
    Sayegh MH; Perico N; Gallon L; Imberti O; Hancock WW; Remuzzi G; Carpenter CB
    Transplantation; 1994 Jul; 58(2):125-32. PubMed ID: 8042230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo mechanisms of alloreactivity. III. Development of donor-specific antibody in sponge matrix allografts.
    Sirinek LP; Zinn NE; Ferguson RM; Orosz CG
    Transplantation; 1986 Mar; 41(3):349-56. PubMed ID: 3952801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immunity in allograft rejection. The role of cytotoxic alloantibody in hyperacute rejection and enhancement of rat cardiac allografts.
    Oluwole SF; Tezuka K; Wasfie T; Stegall MD; Reemtsma K; Hardy MA
    Transplantation; 1989 Nov; 48(5):751-5. PubMed ID: 2815247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased anti-donor major histocompatibility complex class I and increased class II alloantibody response in allograft tolerance in adult rats.
    Cuturi MC; Josien R; Cantarovich D; Bugeon L; Anegon I; Menoret S; Smit H; Douillard P; Soulillou JP
    Eur J Immunol; 1994 Jul; 24(7):1627-31. PubMed ID: 8026523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ transplant specificity of tolerance to skin grafts with heart or kidney grafts plus nondepleting anti-CD4 monoclonal antibody (RIB 5/2) and intravenous donor alloantigen administration.
    Otomo N; Margenthaler JA; Motoyama K; Arima T; Shimizu Y; Lehmann M; Flye MW
    J Surg Res; 2001 Jun; 98(1):59-65. PubMed ID: 11368539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.
    Pan F; Ebbs A; Wynn C; Erickson L; Jang MS; Crews G; Fisniku O; Kobayashi M; Paul LC; Benediktsson H; Jiang AH
    Transplantation; 2003 Apr; 75(8):1110-4. PubMed ID: 12717186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
    Margenthaler JA; Landeros K; Kataoka M; Flye MW
    Transpl Immunol; 2003; 11(1):23-9. PubMed ID: 12727472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FcR blocking activity in serum of actively enhanced rat renal allograft recipients due to IgG anti-class II MHC alloantibody.
    Marshall HE; Bolton EM; Gracie JA; Cocker JE; Sandilands GP; Bradley JA
    Immunology; 1990 Mar; 69(3):379-84. PubMed ID: 2312162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgM and IgG alloantibody production by splenocytes and deposition in rat renal allografts are decreased by donor-specific blood transfusion.
    Baldwin WM; Rhoton K; Sanfilippo F
    Transplantation; 1991 Feb; 51(2):481-5. PubMed ID: 1994544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nontransgenic hyperexpression of a complement regulator in donor kidney modulates transplant ischemia/reperfusion damage, acute rejection, and chronic nephropathy.
    Pratt JR; Jones ME; Dong J; Zhou W; Chowdhury P; Smith RA; Sacks SH
    Am J Pathol; 2003 Oct; 163(4):1457-65. PubMed ID: 14507653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of donor-specific blood transfusion enhancement of rat renal allografts with accelerated development of antiidiotypic antibodies and reduced alloantibody responses.
    Downey WE; Baldwin WM; Sanfilippo F
    Transplantation; 1990 Jan; 49(1):160-6. PubMed ID: 2301006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting complement activation in brain-dead donors improves renal function after transplantation.
    Damman J; Hoeger S; Boneschansker L; Theruvath A; Waldherr R; Leuvenink HG; Ploeg RJ; Yard BA; Seelen MA
    Transpl Immunol; 2011 May; 24(4):233-7. PubMed ID: 21440065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.